50 ML immune globulin intravenous (human) - stwk 100 MG/ML Injection [Alyglo]
RxNorm concept 2672105, branded drug (sbd). Prescribable name: Alyglo 10 % in 50 ML Injection.
- RxCUI
- 2672105
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2672105 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Alyglo 10 % per 50 ML Injection; Alyglo 100 MG/ML per 50 ML Injection; Alyglo 5 GM per 50 ML Injection
Related concepts
- immune globulin intravenous (human) - stwk 100 MG/ML (SCDC, consists of)
- immune globulin intravenous (human) - stwk 100 MG/ML [Alyglo] (SBDC, consists of)
- Injection (DF, has dose form)
- Alyglo (BN, has ingredient)
- 50 ML immune globulin intravenous (human) - stwk 100 MG/ML Injection (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2672105 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2672105 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2672105. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.